首页> 美国卫生研究院文献>Hand (New York N.Y.) >Predictors of Recurrence After Corticosteroid Injection for Trigger Digits
【2h】

Predictors of Recurrence After Corticosteroid Injection for Trigger Digits

机译:皮质类固醇激素注射触发数字后复发的预测因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: We aimed to identify risk factors for recurrence of trigger digit following corticosteroid injection. >Methods: A retrospective review identified patients 18 years and older who presented to a single fellowship-trained hand surgeon with a symptomatic trigger digit during a 1-year period. Baseline demographic data were recorded. Patients with persistent trigger digit after a single injection were offered a second injection. Patients refusing a second injection were excluded from our analysis. Patients with persistent symptoms after 2 injections were offered surgery. For patients with diabetes mellitus, additional information regarding method of disease control and hemoglobin A1c level was recorded. >Results: The overall success of corticosteroid injection was 84% with 16% of patients requiring surgical release. Of the 240 patients successfully treated with injection, 99 (41%) required a second injection. Injections resulted in persistent triggering in 15% of patients with diabetes and 17% of patients without diabetes. A multivariate regression analysis revealed that the 2 strongest risk factors for requiring surgical release were patient age and patients whose fourth digit of the right hand was injected. Diabetes was not a risk factor for persistent triggering after corticosteroid injection. >Conclusions: Our findings can be used to counsel patients prior to their initial injection and suggest that patients with diabetes can be managed with corticosteroid injection with equal efficacy compared with patients without diabetes.
机译:>背景:我们旨在确定皮质类固醇注射后触发数字复发的危险因素。 >方法:回顾性研究确定了18岁及18岁以上的患者,这些患者在1年的时间内就诊于一位接受过研究金培训的手外科医生,并有症状触发数字。记录基线人口统计数据。单次注射后具有持续触发手指的患者将再次注射。拒绝第二次注射的患者被排除在我们的分析之外。两次注射后出现持续症状的患者接受手术治疗。对于糖尿病患者,还记录了有关疾病控制方法和血红蛋白A1c水平的其他信息。 >结果:皮质类固醇注射的总体成功率为84%,其中16%的患者需要手术治疗。在成功注射治疗的240位患者中,有99位(41%)需要再次注射。注射导致15%的糖尿病患者和17%的非糖尿病患者持续触发。多元回归分析显示,需要手术释放的两个最强危险因素是患者年龄和注射右手四指的患者。糖皮质激素注射后,糖尿病不是持续触发的危险因素。 >结论:我们的发现可用于在初次注射患者之前为患者提供咨询,并建议与非糖尿病患者相比,接受糖皮质激素注射治疗的糖尿病患者具有同等效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号